( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , и . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 15 (2): 276–282 (2004)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

Wolfram Engert

Christian Engert

Sabine Engert

Manfred Engert

Brunhild Engert

 

Другие публикации лиц с тем же именем

Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group, , , , , , , , , и 10 other автор(ы). Blood, 92 (12): 4560–4567 (1998)BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group, , , , , , , , , и 15 other автор(ы). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, (1998)A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly), , , , , , , , , и 5 other автор(ы). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 16 (1): 124–131 (2005)Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone, , , , , , , , , и 19 other автор(ы). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 (11): 2905–2914 (2001)Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis, , , , , , и . Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 22 (3): 681–688 (2011)BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group, , , , , , , , , и 15 other автор(ы). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 (12): 3810–3821 (1998)Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial, , , , , , , , , и 21 other автор(ы). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 15 (2): 276–282 (2004)